These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 28895106)

  • 1. Excipient Stability in Oral Solid Dosage Forms: A Review.
    Darji MA; Lalge RM; Marathe SP; Mulay TD; Fatima T; Alshammari A; Lee HK; Repka MA; Narasimha Murthy S
    AAPS PharmSciTech; 2018 Jan; 19(1):12-26. PubMed ID: 28895106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Miniaturized approach for excipient selection during the development of oral solid dosage form.
    Raijada D; Müllertz A; Cornett C; Munk T; Sonnergaard J; Rantanen J
    J Pharm Sci; 2014 Mar; 103(3):900-8. PubMed ID: 24436033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-excipient compatibility screening--role of thermoanalytical and spectroscopic techniques.
    Chadha R; Bhandari S
    J Pharm Biomed Anal; 2014 Jan; 87():82-97. PubMed ID: 23845418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of water in the physical stability of solid dosage formulations.
    Airaksinen S; Karjalainen M; Shevchenko A; Westermarck S; Leppänen E; Rantanen J; Yliruusi J
    J Pharm Sci; 2005 Oct; 94(10):2147-65. PubMed ID: 16136577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of Polymers as Pharmaceutical Excipients in Solid Oral Dosage Forms.
    Debotton N; Dahan A
    Med Res Rev; 2017 Jan; 37(1):52-97. PubMed ID: 27502146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of excipient interactions on solid dosage form stability.
    Narang AS; Desai D; Badawy S
    Pharm Res; 2012 Oct; 29(10):2660-83. PubMed ID: 22707362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits of Fractal Approaches in Solid Dosage Form Development.
    Abreu-Villela R; Kuentz M; Caraballo I
    Pharm Res; 2019 Sep; 36(11):156. PubMed ID: 31493266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative Manufacturing Concepts for Solid Oral Dosage Forms From Drug Nanosuspensions Using Fluid Dispensing and Forced Drying Technology.
    Bonhoeffer B; Kwade A; Juhnke M
    J Pharm Sci; 2018 Mar; 107(3):909-921. PubMed ID: 29154900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase transformation considerations during process development and manufacture of solid oral dosage forms.
    Zhang GG; Law D; Schmitt EA; Qiu Y
    Adv Drug Deliv Rev; 2004 Feb; 56(3):371-90. PubMed ID: 14962587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Porous Excipients on the Manufacturability and Product Performance of Solid Self-Emulsifying Drug Delivery Systems.
    Beringhs AO; Minatovicz BC; Zhang GGZ; Chaudhuri B; Lu X
    AAPS PharmSciTech; 2018 Oct; 19(7):3298-3310. PubMed ID: 30218264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levothyroxine Sodium Pentahydrate Tablets - Formulation Considerations.
    Kaur N; Suryanarayanan R
    J Pharm Sci; 2021 Dec; 110(12):3743-3756. PubMed ID: 34384799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact Of Excipient Variability On Drug Product Processing And Performance.
    Peng Soh JL; Liew CV; Sia Heng PW
    Curr Pharm Des; 2015; 21(40):5890-9. PubMed ID: 26446469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excipient variability and its impact on dosage form functionality.
    Dave VS; Saoji SD; Raut NA; Haware RV
    J Pharm Sci; 2015 Mar; 104(3):906-15. PubMed ID: 25561249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of pharmaceutical salts in solid oral dosage forms.
    Nie H; Byrn SR; Zhou QT
    Drug Dev Ind Pharm; 2017 Aug; 43(8):1215-1228. PubMed ID: 28276282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypromellose - A traditional pharmaceutical excipient with modern applications in oral and oromucosal drug delivery.
    Mašková E; Kubová K; Raimi-Abraham BT; Vllasaliu D; Vohlídalová E; Turánek J; Mašek J
    J Control Release; 2020 Aug; 324():695-727. PubMed ID: 32479845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zein as a Pharmaceutical Excipient in Oral Solid Dosage Forms: State of the Art and Future Perspectives.
    Berardi A; Bisharat L; AlKhatib HS; Cespi M
    AAPS PharmSciTech; 2018 Jul; 19(5):2009-2022. PubMed ID: 29736888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent trends in stabilising peptides and proteins in pharmaceutical formulation - considerations in the choice of excipients.
    Jorgensen L; Hostrup S; Moeller EH; Grohganz H
    Expert Opin Drug Deliv; 2009 Nov; 6(11):1219-30. PubMed ID: 19678792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biopharmaceutical aspects and implications of excipient variability in drug product performance.
    Zarmpi P; Flanagan T; Meehan E; Mann J; Fotaki N
    Eur J Pharm Biopharm; 2017 Feb; 111():1-15. PubMed ID: 27845182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FIP Guidelines for Dissolution Testing of Solid Oral Products.
    Friedel HD; Brown CK; Barker AR; Buhse LF; Keitel S; Kraemer J; Morris JM; Reppas C; Sperry DC; Sakai-Kato K; Stickelmeyer MP; Shah VP
    J Pharm Sci; 2018 Dec; 107(12):2995-3002. PubMed ID: 30148985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.